Trial diversity-it’s time to quit talking and start doing
In order to improve diversity in trials inequities due to economic factors and race need to be bridged at institutional…
By
Analysis
Latest in
Analysis
Asia-Pacific has seen the largest growth in oncology-related trials over the past decade
We've analysed 10 years' worth of clinical trials data from GlobalData to pick out key geographic trends.
By
3D printing in drug manufacturing: unlocking future possibilities
From personalised medicine to the democratisation of drug access, XIL Health founder and CEO Susan Lang believes 3D printing can…
By
iOnctura targets the tumor stroma interface to win over immunotherapy resistance
The Swiss firm is advancing its cancer therapies in the clinic while it gears up to raise funds
By
Pharma developments in 2022: what you need to know
A look at healthcare trends that will likely impact pharma's efforts to research and develop therapeutics in 2022
By
The future of medtech goes beyond Microsoft’s AI creep
What to expect from medtech and its future beyond the ‘Monstersoft’ in the operating room.
By
The challenges of multiple drugs safety reporting
Pharmacovigilance of a single drug is one thing, but investigating an adverse event in case of polypharmacy is even more…
By
Filings buzz in pharma: 64% increase in internet of things mentions in Q2 of 2021
Internet of things mentions have increased 280% in the filings of companies in the pharmaceutical industry since 2016
By